- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Therapeutic Choice and Outcomes at the Physician Level
Anupam Jena, MD, PhD, Assistant Professor of Healthcare Policy, Harvard Medical School, presented research on how therapeutic choice and patient outcomes vary at the physician level.
Anupam Jena, MD, PhD, Assistant Professor of Healthcare Policy, Harvard Medical School, presented research on how therapeutic choice and patient outcomes vary at the physician level. Dr. Jena said that improving US healthcare will rely on better measuring and learning how to shape physician behavior. Throughout this segment, Dr. Jena presents a study that aimed to determine what makes sense for a physician-based measure of performance in diabetes care. He said that the goal was to:
- To propose a measure to study physician level performance in diabetes care.
- To study how the measure varied across physicians.
- To identify high and low performing physicians and see how they differ.
- How many adverse complications related to diabetes be avoided.
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
